Journal article
Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist
Experimental cell research, Vol.319(17), pp.2578-2587
10/15/2013
DOI: 10.1016/j.yexcr.2013.07.005
PMCID: PMC3797157
PMID: 23911939
Abstract
FLT1 and its soluble form (sFLT1) arise as alternate transcripts from the same gene and sFLT1 can antagonize the effect of vascular endothelial growth factor (VEGF) on its cognate receptors. We investigated the effect of VEGF and protein kinase C (PKC) activation on sFLT1 abundance. We demonstrated that VEGF stimulates sFLT1 and FLT1 mRNA and protein levels in vascular endothelial cells via VEGFR2 and PKC. Using an FLT1 expression vector with N and C-terminal epitope tags, we show that PKC activation increases the cleavage of FLT1 into an N-terminal extracellular fragment and a C-terminal intracellular fragment with the cleavage occurring adjacent to the transmembrane domain. The trafficking and glycosylation inhibitors brefeldin, monensin and tunicamycin substantially reduced cleavage and release of the N-terminal ectodomain of FLT1 and inhibited secretion of the isoforms of sFLT1. The shed FLT1 ectodomain can bind VEGF and PlGF and inhibit VEGF-induced vascular tube formation thus confirming that it is functionally equivalent to the alternately spliced and secreted sFLT1 isoforms.
•We investigated the effect of VEGF and PKC activation on sFLT1 and Flt1 expression.•We demonstrate that VEGF stimulates sFLT1 and FLT1 in vascular endothelial cells via VEGFR2 and PKC.•We show that PKC activation stimulates the cleavage of FLT1 into an N-terminal ectodomain and a C-terminal intracellular fragment.•The shed FLT1 ectodomain can bind PlGF and VEGF and inhibit VEGF-induced vasculogenesis.•The study confirms that the Flt1 ectodomain is functionally equivalent to the alternately transcribed and secreted sFLT1 isoforms.
Details
- Title: Subtitle
- Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist
- Creators
- Nandita S Raikwar - Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USAKang Z Liu - Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USAChristie P Thomas - Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- Experimental cell research, Vol.319(17), pp.2578-2587
- DOI
- 10.1016/j.yexcr.2013.07.005
- PMID
- 23911939
- PMCID
- PMC3797157
- NLM abbreviation
- Exp Cell Res
- ISSN
- 0014-4827
- eISSN
- 1090-2422
- Publisher
- Elsevier Inc
- Grant note
- name: New Directions Grant from the American Society of Nephrology; name: VA Merit Review Award; DOI: 10.13039/100000002, name: National Institutes of Health, award: RO1 DK090053
- Language
- English
- Date published
- 10/15/2013
- Academic Unit
- Stead Family Department of Pediatrics; Obstetrics and Gynecology; Internal Medicine
- Record Identifier
- 9983986081902771
Metrics
18 Record Views